These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15642687

  • 1. Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy.
    Pession A, Barbieri E, Santoro N, Paolucci P, Porta F, Locatelli F.
    Haematologica; 2005 Jan; 90(1):141-2. PubMed ID: 15642687
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome.
    Kikuchi A, Kigasawa H, Tsurusawa M, Kawa K, Kikuta A, Tsuchida M, Nagatoshi Y, Asami K, Horibe K, Makimoto A, Tsukimoto I.
    Int J Hematol; 2009 Nov; 90(4):492-500. PubMed ID: 19701676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.
    Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey BR, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown A, Laadem A, Seiter K.
    J Clin Oncol; 2010 Sep 20; 28(27):4207-13. PubMed ID: 20713865
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of rasburicase (recombinant urate oxidase) in the prevention and treatment of malignancy-associated hyperuricemia: an Indian experience.
    Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM.
    Indian J Cancer; 2014 Sep 20; 51(2):180-3. PubMed ID: 25104205
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
    Bose P, Qubaiah O.
    J Clin Pharm Ther; 2011 Jun 20; 36(3):299-326. PubMed ID: 21501203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome.
    Knoebel RW, Lo M, Crank CW.
    J Oncol Pharm Pract; 2011 Sep 20; 17(3):147-54. PubMed ID: 20332174
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment and prevention of tumor lysis syndrome in children. Experience of Associazione Italiana Ematologia Oncologia Pediatrica.
    Pession A, Barbieri E.
    Contrib Nephrol; 2005 Sep 20; 147():80-92. PubMed ID: 15604608
    [Abstract] [Full Text] [Related]

  • 17. Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.
    Herrington JD, Dinh BC.
    J Oncol Pharm Pract; 2015 Apr 20; 21(2):111-7. PubMed ID: 24549060
    [Abstract] [Full Text] [Related]

  • 18. Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
    Navolanic PM, Pui CH, Larson RA, Bishop MR, Pearce TE, Cairo MS, Goldman SC, Jeha SC, Shanholtz CB, Leonard JP, McCubrey JA.
    Leukemia; 2003 Mar 20; 17(3):499-514. PubMed ID: 12646938
    [Abstract] [Full Text] [Related]

  • 19. Rasburicase for the treatment and prevention of hyperuricemia.
    Yim BT, Sims-McCallum RP, Chong PH.
    Ann Pharmacother; 2003 Mar 20; 37(7-8):1047-54. PubMed ID: 12841818
    [Abstract] [Full Text] [Related]

  • 20. Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's lymphoma.
    Rényi I, Bárdi E, Udvardi E, Kovács G, Bartyik K, Kajtár P, Masát P, Nagy K, Galántai I, Kiss C.
    Pathol Oncol Res; 2007 Mar 20; 13(1):57-62. PubMed ID: 17387390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.